Anti-Toxoplasma gondii activities and structure-activity relationships of novel fluoroquinolones related to trovafloxacin

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 7, 1999, Pages 1783-1787

  Khan, Anis A ^a,b   Araujo, Fausto G ^a   Brighty, Katherine E ^c   Gootz, Thomas D ^c   Remington, Jack S ^a,b  

^a PALO ALTO MEDICAL FOUNDATION   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; CIPROFLOXACIN; CYCLOHEXANE DERIVATIVE; METHYL GROUP; NAPHTHYRIDINE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEMAFLOXACIN; TOSUFLOXACIN; TROVAFLOXACIN;

ANTIBIOTIC THERAPY; ANTIPROTOZOAL ACTIVITY; ARTICLE; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; FIBROBLAST; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TOXICITY TESTING; TOXOPLASMA GONDII;

EID: 0032812518     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.7.1783     Document Type: Article

References (8)

1. Araujo, F. G., J. Huskinson, and J. S. Remington. 1991. Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii. Antimicrob. Agents Chemother. 35:293-299.
2. Drlica, K., and X. Zhao. 1997. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev. 61:377-392.
3. Fichera, M. E., and D. S. Roos. 1997. A plastid organelle as a drug target in apicomplexan parasites. Nature 390:407-409.
4. Hooper, D. C. 1995. Quinolones, p. 364-376. In G. L. Mandell and J. E. Bennett (ed.), Principles and practice of infectious diseases, 4th ed., vol. 1. Churchill Livingstone, New York, N.Y.
5. Khan, A. A., T. Slifer, F. G. Araujo, R. J. Polzer, and J. S. Remington. 1997. Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis. Antimicrob. Agents Chemother. 41:893-897.
6. Khan, A. A., T. Slifer, F. G. Araujo, and J. S. Remington. 1996. Trovafloxacin is active against Toxoplasma gondii. Antimicrob. Agents Chemother. 40:1855-1859.
7. Pan, X.-S., and L. M. Fisher. 1997. Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones. Antimicrob. Agents Chemother, 41:471-474.
8. Teng, R., S. C. Harris, D. E. Nix, J. J. Schentag, G. Foulds, and T. E. Liston. 1995. Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers. J. Antimicrob. Chemother. 36:385-394.